- Home
- GOCO vs CRVO Comparison
GOCO vs CRVO Comparison
Compare GOCO & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOCO
- CRVO
- Stock Information
- Founded
- GOCO 2001
- CRVO 2001
- Country
- GOCO United States
- CRVO United States
- Employees
- GOCO N/A
- CRVO N/A
- Industry
- GOCO Specialty Insurers
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- GOCO Finance
- CRVO Health Care
- Exchange
- GOCO Nasdaq
- CRVO Nasdaq
- Market Cap
- GOCO 64.9M
- CRVO 67.4M
- IPO Year
- GOCO 2020
- CRVO N/A
- Fundamental
- Price
- GOCO $4.98
- CRVO $8.85
- Analyst Decision
- GOCO Hold
- CRVO Strong Buy
- Analyst Count
- GOCO 1
- CRVO 6
- Target Price
- GOCO $12.00
- CRVO $19.17
- AVG Volume (30 Days)
- GOCO 44.9K
- CRVO 115.4K
- Earning Date
- GOCO 11-06-2025
- CRVO 11-11-2025
- Dividend Yield
- GOCO N/A
- CRVO N/A
- EPS Growth
- GOCO N/A
- CRVO N/A
- EPS
- GOCO N/A
- CRVO N/A
- Revenue
- GOCO $822,444,000.00
- CRVO $7,776,968.00
- Revenue This Year
- GOCO $4.66
- CRVO N/A
- Revenue Next Year
- GOCO $6.95
- CRVO N/A
- P/E Ratio
- GOCO N/A
- CRVO N/A
- Revenue Growth
- GOCO 17.46
- CRVO N/A
- 52 Week Low
- GOCO $4.65
- CRVO $1.80
- 52 Week High
- GOCO $21.00
- CRVO $20.63
- Technical
- Relative Strength Index (RSI)
- GOCO 42.52
- CRVO 42.79
- Support Level
- GOCO $4.65
- CRVO $9.61
- Resistance Level
- GOCO $4.98
- CRVO $10.48
- Average True Range (ATR)
- GOCO 0.27
- CRVO 0.61
- MACD
- GOCO -0.00
- CRVO -0.15
- Stochastic Oscillator
- GOCO 34.18
- CRVO 6.85
About GOCO GoHealth Inc.
GoHealth Inc is a health insurance marketplace and Medicare-focused digital health company whose purpose is to compassionately ensure consumers' peace of mind when making healthcare decisions so consumers can focus on living life. It offers Medicare plans, including, but not limited to, Medicare Advantage, Medicare Supplement and prescription drug plans. Its proprietary technology platform leverages modern machine-learning algorithms, powered by over two decades of insurance purchasing behavior, to reimagine the process of matching a health plan to a consumer's specific needs.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.